The KIDINS220 gene helps nerve cells grow, connect, and pass signals, especially as the brain develops. If it does not work properly, the nervous system may not develop in the usual way, which can lead to developmental delay, differences in learning, movement problems, and sometimes seizures or vision changes. This gene plays an important role in how your body builds and maintains healthy nerve networks.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, which are the working parts of cells. Other genes mainly help determine when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes influence how the body grows and works, and they can affect how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
KIDINS220Gene function
What if the gene works
The KIDINS220 gene helps nerve cells grow, connect, and send signals. Its protein supports communication pathways that help guide brain development and help some other cells, including heart and immune cells, respond to everyday signals.
Risk
What if the gene does not work
More disruptive variants in the KIDINS220 gene are linked to a condition that can affect brain and nerve development, often causing developmental delay or intellectual disability, muscle stiffness, and unusual eye movements. Milder variants may lead to a milder pattern.
Treatment
What does that mean for your treatment
No KIDINS220-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the KIDINS220 gene. Care is based on the person's symptoms, and the KIDINS220 gene is mainly being studied in nerve signaling and as a possible biomarker or drug target in some cancers, not yet for guideline-based treatment choices.
Conditions associated with KIDINS220
Gene function
What if the gene works
Your brain and nerves depend on steady signals as cells grow, connect, and adapt. The KIDINS220 gene helps organize these messages inside cells. It is especially active in nerve cells, where clear signaling supports healthy development and communication.
The KIDINS220 gene helps link cell surface receptors to the signaling systems inside the cell. This lets incoming messages be passed along in a more coordinated way.
It supports the growth and shaping of nerve cell branches, which help cells reach the right targets. This role is part of how the KIDINS220 gene helps nerve cells communicate in organized networks.
Many cells use KIDINS220 to respond to nerve growth signals that guide development and everyday upkeep. These signals help cells adjust their activity, maintain connections, and stay responsive.
In nerve cells, KIDINS220 helps support synapses, the contact points where cells pass messages to each other. This contributes to stable communication and ongoing changes that help networks adapt.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help account for normal differences among people, including appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KIDINS220 gene often reduce the amount of working protein or create a shortened protein that cannot interact normally with partner proteins, so cell signaling becomes less stable. This is the main pattern behind how KIDINS220 gene variants affect protein function. Milder variants may leave some activity, while more severe variants can remove most activity and may be linked to symptoms appearing earlier or affecting more areas.
How variants are linked to conditions
When looking at how KIDINS220 gene variants are linked to conditions, the main confirmed association is a rare neurodevelopmental condition called SINO syndrome. People with pathogenic variants may have developmental delay or intellectual disability, muscle stiffness or walking problems, unusual eye movements such as nystagmus, and sometimes obesity. Features can vary from person to person, but this is a well-established genetic diagnosis rather than a general risk marker.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks related to the KIDINS220 gene. When a disease-causing KIDINS220 change is present, the chance of related problems is usually driven mainly by that genetic change rather than by day-to-day habits.
Inheritance of KIDINS220 variants
For the conditions currently linked to the KIDINS220 gene, the KIDINS220 gene inheritance pattern is autosomal dominant. This means one altered copy can be enough to cause the condition, so an affected parent can pass it to a child with a 50% chance in each pregnancy. Many reported cases happen because of a new, de novo variant in the KIDINS220 gene, which means the change started in the child and was not inherited from either parent.
What does my KIDINS220 result mean for my family?
For KIDINS220, the best-known related condition is usually passed in a dominant way, so a parent, brother, sister, or child may also carry the same gene change. In many families, though, the change happens for the first time in one person and is not inherited from either parent. This means the family impact can differ from one household to another.
Genetic information
Genetic testing
How you find out about variants
KIDINS220 genetic testing looks for variants in the KIDINS220 gene using a blood sample, saliva, or sometimes cheek cells. A lab reads the gene's DNA sequence and checks for changes linked to a person's features or diagnosis. Results may confirm a variant, rule one out, or find a change of uncertain meaning.
When should I consider getting a genetic test?
Genetic testing for the KIDINS220 gene may be worth considering when a child has unexplained developmental delay, low muscle tone or stiffness, unusual eye movements, hearing loss, or a similar family history. It can also help families understand whether a relative’s known KIDINS220 change could affect another pregnancy.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the type of variant involved. Over time, lifestyle, environment, age, and medical history also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work. By looking at gene drug patterns, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects are. This information can support more informed and individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the KIDINS220 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about treatment, side effects, or changes in how you feel are best discussed with your doctor or pharmacist.
History
KIDINS220 entered the research literature in the early 2000s, when scientists identified it while studying proteins involved in cell signaling in the nervous system. It was first named kinase D interacting substrate of 220 kDa, which is where the KIDINS220 gene name comes from. Building on this early work, researchers traced its activity in brain development and nerve cell communication. As genetic testing became more widely used, rare variants in the KIDINS220 gene were linked to a neurodevelopmental condition now called spastic paraplegia, intellectual disability, nystagmus, and obesity syndrome. Over time, descriptions became more precise. Today, KIDINS220 is recognized mainly through modern sequencing studies rather than through a long public or cultural history.